Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma.
Waldschmidt JM, Sotudeh N, Arora S, Vijaykumar T, Anand P, Stuart H, Frede J, Campbell TB, Kaiser S, Zheng X, Munshi NC, Anderson KC, Einsele H, Yee AJ, Knoechel B, Lohr JG, Raje NS.
Waldschmidt JM, et al. Among authors: arora s.
Blood Adv. 2025 Jan 15:bloodadvances.2024015285. doi: 10.1182/bloodadvances.2024015285. Online ahead of print.
Blood Adv. 2025.
PMID: 39813623